It is well known that somatomedin is one of the growth factors. Somatomedin activity is detected with a biological assay system which measures glycosaminoglycan synthesis and thymidine uptake into cartilage. However, there are a variety of factors which regulate cartilage growth and somatomedin activity. It has recently been reported that serum and/or somatomedin effects on cartilage depend on the type of cartilage (Ash et al., 1975 , Corvol et al., 1978 , Hill et al., 1979 . Phillips et al., (1982) reported that the growth plate is more responsive than resting cartilage.
It is well known that somatomedin is one of the growth factors. Somatomedin activity is detected with a biological assay system which measures glycosaminoglycan synthesis and thymidine uptake into cartilage. However, there are a variety of factors which regulate cartilage growth and somatomedin activity. It has recently been reported that serum and/or somatomedin effects on cartilage depend on the type of cartilage (Ash et al., 1975 , Corvol et al., 1978 , Hill et al., 1979 . Phillips et al., (1982) reported that the growth plate is more responsive than resting cartilage.
In the present study, using cultured rat chondrocytes isolated from growth cartilage, we have investigated the effects of growth factors and hormones on glycosaminoglycan synthesis. This preparation was purified from human plasma essentially as previously described (Fryklund et al., 1974) and had a biological activity of 80 U/mg as determined by radioreceptor assay for somatomedin A (Takano et al., 1976) . Since there is still no uniform standard somatomedin A available for the radioreceptor assay, pooled human serum was used as an arbitrary reference. One unit (U) of somatomedin A is here defined as the somatomedin content in one milliliter 
Results
The effects of somatomedin A and insulin on GAG synthesis are shown in Figure  1 .
We observed a dose dependent increase in GAG synthesis within the range of 4-64 mU/ ml of somatomedin A, and 50-1000 ng/ml of insulin, respectively. A significat increase in GAG synthesis was observed at a somatomedin A concentration of 16 mU/ml, which is the physiological level of somatomedin in serum. However, 500 ng/ml of insulin was required to obtain a significant increase in GAG synthesis, which is 500 times higher than the physiological concentation in serum.
Other growth factors, epidermal growth factor (EGF) and fibroblast growth factor (FGF), were also used in these studies. We observed no significant increase in GAG synthesis when EGF and FGF were used up to concentration of 20 ng/ml and 800 ng/ml, respectively (Table 1 ). The effects of other hormones on GAG synthesis were studied. ( Table 1) . Human serum stimulated GAG synthesis as a function of the serum concentration when the serum was added up to a concentration of 1%. However GAG synthesis began to decrease when the serum concentration was over 2%. Therefore we used serum concentrations between 0.2% and 1% for GAG synthesis. Serum from three patients with acromegaly had stimulated GAG synthesis more than that from three patients with hypopituitarism, as shown in Table 2 . However, the differences were not always significant.
Discussion
Using a rat chondrocyte culture system, GAG synthesis was monitored by measuring incorporation of 35S-sulphate into chondroitin sulphate.
Somatomedin A at the physiological concentration of 16 mU/ml stimulated GAG synthesis significantly.
However, insulin at the physiological concentration did not stimulate GAG synthesis, and pharmacological doses as large as 500 ng/ml were required to induce significant GAG synthesis. These observations suggest that, under physiological conditions, insulin is not related (Keret et al., 1976 , Tessler et al., 1975 , Phillips et al., 1975 . 
